Ioannis Stouras, Associate Researcher National and Kapodistrian University of Athens, shared on X:
“Why hasn’t any new biomarker complemented PD-L1 CPS in head and neck cancer immunotherapy?
Our answer, born out of my PhD, is now out in Cancer Treatment Reviews.”
Title: Tissue and blood-based biomarkers of immunotherapy response in head and neck Cancer
Authors: Ioannis Stouras, Evangelos Zazas, Maria Cossu Rocca, Mohssen Ansarin, Amanda Psyrri
Read the Full Article
You may also be interested in:
- Immune Oncology Research Institute Highlights KEYNOTE-689 Results in Head and Neck Cancer
- Zolbetuximab and Immunotherapy Across PD-L1 CPS in Advanced Gastric and GEJ Cancer
